ResearchAI Research

CALM Aligns Brain Imaging and Genetics for Biomarker Discovery.

Jueqi Wang, Zachary Jacokes, John Darrell Van Horn, Kevin A. Pelphrey, Michael C. Schatz, Archana Venkataraman· July 3, 2026 View original

▶ The 2-minute explainer

Summary

CALM is a framework that learns interpretable associations between brain regions and genetic pathways from separate neuroimaging and genetics datasets. It aligns these modalities in a shared latent space, outperforming state-of-the-art methods in biomarker discovery for neuropsychiatric disorders like autism.

This research introduces CALM, a novel framework designed to uncover meaningful connections between brain structure and genetic influences, which are crucial for understanding neuropsychiatric conditions. A significant challenge in this field is that most large-scale datasets are unimodal, meaning they contain either neuroimaging data or genetic information, but rarely both for the same individuals. CALM addresses this by learning interpretable associations between brain regions of interest (ROIs) and genetic pathways even when the data comes from completely disjoint populations. The core of CALM involves aligning the two distinct modalities into a common latent space. This is achieved through linear projections that simultaneously ensure that the class-conditional latent distributions match and that different groups (e.g., healthy vs. diseased) remain separable. These projections are designed to be interpretable, directly revealing the pathway-ROI associations. When tested on unimodal imaging and genetics datasets, CALM demonstrated superior performance compared to existing state-of-the-art methods and baseline approaches, even generalizing effectively to previously unseen paired datasets. Experiments on autism spectrum disorder (ASD) using CALM identified immune and metabolic pathways linked to specific cortical regions, findings consistent with established scientific literature. This capability opens new avenues for leveraging vast unimodal data repositories to study complex cross-modal interactions in brain disorders.

Why it matters

Professionals in healthcare, pharmaceuticals, and AI for medicine can use this framework to accelerate biomarker discovery, improve understanding of complex diseases, and potentially develop more targeted treatments.

How to implement this in your domain

  1. 1Explore applying CALM to existing unimodal datasets in neuroscience or other biological domains to uncover novel cross-modal relationships.
  2. 2Collaborate with research institutions to validate CALM's findings on specific neuropsychiatric disorders.
  3. 3Develop tools or platforms that integrate CALM's methodology for automated biomarker discovery from disparate data sources.
  4. 4Investigate the interpretability features of CALM to gain deeper biological insights into disease mechanisms.

Who benefits

HealthcarePharmaceuticalsBiotechnologyMedical Research

Key takeaways

  • CALM enables interpretable cross-modal alignment of unpaired brain imaging and genetic data.
  • It helps discover biomarkers and understand neuropsychiatric disorders like autism.
  • The framework aligns modalities in a shared latent space via interpretable linear projections.
  • CALM outperforms state-of-the-art methods and reveals biologically consistent associations.

Original post by Jueqi Wang, Zachary Jacokes, John Darrell Van Horn, Kevin A. Pelphrey, Michael C. Schatz, Archana Venkataraman

"arXiv:2607.01656v1 Announce Type: new Abstract: The interaction between brain structure and genetic influences is key to understanding neuropsychiatric disorders. However, most large-scale datasets are unimodal, providing either neuroimaging or genetics data. We propose CALM, a f…"

View on X

Originally posted by Jueqi Wang, Zachary Jacokes, John Darrell Van Horn, Kevin A. Pelphrey, Michael C. Schatz, Archana Venkataraman on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses